• PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors
  Kotlinowski J, Grochot-Przeczek A, Taha H, Kozakowska M, Pilecki B, Skrzypek K, Bartelik A, Derlacz R, Horrevoets AJ, Pap A, Nagy L, Dulak J, Jozkowicz A.
  Cardiovasc Diabetol. 2014; 13: 150
  
• Elevated serum osteoprotegerin is associated with decreased osteoclastic differentiation in stenotic aortic valves.
  Lis GJ, Czubek U, Jasinska M, Jasek E, Loboda A, Dulak J, Nessler J, Sadowski J, Litwin JA.
  J Physiol Pharmacol. 2014;65: 377-382
  
• Number of circulating pro-angiogenic cells, growth factor and anti-oxidative gene profiles might be altered in type 2 diabetes with and without diabetic foot syndrome.
  Nowak WN, Borys S, Kusińska K, Bukowska-Strakova K, Witek P, Koblik T, Józkowicz A, Małecki MT, Dulak J.
  J Diabetes Investig. 2014; 5: 99-107
  
• MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development.
  Cieśla M, Dulak J, Józkowicz A.
  Int J Biochem Cell Biol. 2014; 53C: 482-492
  
• Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1.
  Tertil M, Skrzypek K, Florczyk U, Weglarczyk K, Was H, Collet G, Guichard A, Gil T, Kuzdzal J, Jozkowicz A, Kieda C, Pichon C, Dulak J.
  PLoS One. 2014; 9: e97070
  
• Comment on: The proper criteria for identification and sorting of very small embryonic-like stem cells, and some nomenclature issues.
  Szade K, Bukowska-Strakova K, Nowak WN, Jozkowicz A, Dulak J.
  Stem Cells Dev. 2014; 23: 714-716
  
• Novel faces of heme oxygenase-1: mechanisms and therapeutic potentials.
  Dulak J, Jozkowicz A.
  Antioxid Redox Signal. 2014; 20: 1673-1676
  
• Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization.
  Grochot-Przeczek A, Kotlinowski J, Kozakowska M, Starowicz K, Jagodzinska J, Stachurska A, Volger OL, Bukowska-Strakova K, Florczyk U, Tertil M, Jazwa A, Szade K, Stepniewski J, Loboda A, Horrevoets AJ, Dulak J, Jozkowicz A.
  Antioxid Redox Signal. 2014; 20: 1677-1692
  
• Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.
  Collet G, Lamerant-Fayel N, Tertil M, El Hafny-Rahbi B, Stepniewski J, Guichard A, Foucault-Collet A, Klimkiewicz K, Petoud S, Matejuk A, Grillon C, Jozkowicz A, Dulak J, Kieda C.
  Mol Cancer Ther. 2014; 13: 165-178
  
• Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs.
  Kozakowska M, Szade K, Dulak J, Jozkowicz A.
  Antioxid Redox Signal. 2014;20: 1827-1850
  
• Nrf2 regulates angiogenesis: effect on endothelial cells, bone marrow-derived proangiogenic cells and hind limb ischemia.
  Florczyk U, Jazwa A, Maleszewska M, Mendel M, Szade K, Kozakowska M, Grochot-Przeczek A, Viscardi M, Czauderna S, Bukowska-Strakova K, Kotlinowski J, Jozkowicz A, Loboda A, Dulak J.
  Antioxid Redox Signal. 2014; 20:1693-1708
  

Chapters in the book: Angiogenesis and vascularisation – cellular and molecular mechanisms in health and diseases, Edited by Józef Dulak, Alicja Józkowicz, Agnieszka Łoboda, Publisher: Springer, 2014, ISBN: 978-3-7091-1427-8:

• Endothelial cell origin, differentiation, heterogeneity and function
  Grochot-Przęczek A, Kozakowska M, Dulak J, Józkowicz A.
  
  
• Nrf2 transcription factor and heme oxygenase-1 as modulators of vascular injury and angiogenesis
  Florczyk U, Józkowicz A, Dulak J.
  
  
• Molecular mechanisms of hypoxia-regulated angiogenesis.
  Łoboda A, Józkowicz A, Dulak J.
  
  
• Signaling and structural abnormalities in tumor angiogenesis.
  Tertil M, Skrzypek K, Łoboda A.
  
  

« 2013 | 2015 »